OB-GYN dr. Luke McLindon's data show 147% increase in miscarriage rate post-vax, possible shedding

Obstetrician-gynecologist (OB-GYN) dr. Luke McLindon has been keeping accurate data from his own patients (with their consent) from before and during the COVID jab roll-out.

The normal spontaneous miscarriage rate is age-dependent: it increases strongly after the age of 30. The average spontaneous miscarriage rate is 13-15%.

The miscarriage rate of 51 patients treated by dr. McLindon between September 2020 and July 2021 ('pre-vaxx guideline period') was 19.6%.

The miscarriage rate of 62 patients treated by dr. McLindon between August 2021 and June 2022 ('post-vaxx guideline period') was 48.4%.

This is a 147% increase compared to the pre-vaxx guideline period. The chance that this increase happened by chance is 1 in 1000, so extremely unlikely.

Age is not a confounding factor in the observed difference, since the average age was only very slightly higher. Maybe only 1% of the increase might be due to higher age.

Other data observed by dr. McLindon:

* 3 out of 4 women (75%) who were injected between 5 and 12 weeks, miscarried. While the sample size is small, the figures are in the same order of magnitude as a study published in the New England Journal of Medicine in 2021. This study showed about a 70%+ miscarriage rate when injected during the first trimester.
* Of the 21 women who got injected starting during their second or third trimester, all but 1 proceeded to live birth.

This is a signal that the largest risk of miscarriage is when you're injected shortly before pregnancy or during the first trimester.

* None of the 8 women who received a booster during any stage in their pregnancy, miscarried.

* The elevated miscarriage rate of about 50% in the post-vaxx guideline group seems to affect both injected and the non-injected, although the sample size is relatively small: 22 miscarriages out of 48 vaxxed women, and 5 miscarriages in 10 unvaxxed women. This is a signal of possible vaxx shedding.

The FDA defines 'shedding' as follows:

"For purposes of this guidance, the term “shedding” means release of VBGT [Virus or Bacteria-based Gene Therapy] or oncolytic products from the patient through one or all of the following ways: excreta (feces); secreta (urine, saliva, nasopharyngeal fluids etc.); or through the skin (pustules, sores, wounds)."

https://www.fda.gov/media/89036/download

SOURCE

Segment from (starts at 12 min in original):
https://rumble.com/v1hlh5b